Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001520138-21-000689
Filing Date
2021-10-29
Accepted
2021-10-29 17:09:56
Documents
1
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3131
  Complete submission text file 0001520138-21-000689.txt   4547
Mailing Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404
Business Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404 310-444-4300
BIOVIE INC. (Issuer) CIK: 0001580149 (see all company filings)

EIN.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 CUMMINGS CENTER 247C BEVERLY MA 01915
Business Address
Adams Jonathan M (Reporting) CIK: 0001749582 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39015 | Film No.: 211364215